Huge cancer summit coming to Copenhagen

Oncology experts will discuss the most effective cancer treatment solutions

Leading international experts on cancer will meet in Copenhagen this October at one of the top summits on oncology research in an attempt to find the most effective treatments.

The European Society for Medical Oncology’s (ESMO) congress will take place at the Bella Center in Amager from October 7-11.

READ MORE: Danish discovery could revolutionise cancer treatment

The conference will offer a top-level scientific and educational program and feature presentations of targeted therapies and immunotherapeutic approaches as well as joint symposia with representatives of all oncology specialties.

Some of the presentations will be streamed online, so it is possible to register for webcast access only.

The congress will also provide an opportunity to network with major pharmaceutical companies at the exhibition and Satellite Symposia.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.